XYouTubeLinkedInSoundCloudFacebookInstagram

Events for Fri, December 13, 2024 - September 25, 2018

Views Navigation

Event Views Navigation

Today

Diversity, Equity and Inclusion (DEI) in the Workplace: Developing Actionable Objectives

More and more companies today recognize the importance of a diverse and inclusive workplace in achieving organizational success. By embracing diversity, equity, and inclusion (DEI), businesses can attract and retain the best talent, drive innovation, and strengthen their brand. However, some organizations still struggle to establish concrete diversity goals and implement transformative strategies that effectively promote DEI. Thus, to thrive in this modern business landscape, companies must take decisive and proactive steps in creating a positive and progressive work environment. In this CLE Webcast, a panel of thought leaders and practitioners will discuss the importance of DEI in the workplace [...]

A Review of Immigration Policies: Key Facts Explored

Immigration policies have taken center stage in the global discourse, shaping the destinies of individuals, influencing economies, and challenging governments. These policies are not merely regulatory frameworks but are laden with profound socio-political implications that resonate far beyond borders. In an increasingly interconnected world, understanding the intricacies of immigration policies is crucial for individuals, businesses, policymakers, and advocates alike.

Unveiling the Impact: Notable Developments Shaping Restrictive Covenants

In the ever-evolving world of employment law, restrictive covenants have become essential tools for safeguarding business interests, intellectual property, and trade secrets. Crafting and enforcing these covenants, however, necessitates precision to avoid legal challenges. Enforceable restrictive covenants must strike a delicate balance, being reasonable in terms and scope while adhering to federal and state laws. In this LIVE Webcast, experienced commercial litigators Ronald M. Rosengarten (Greenberg Traurig, LLP) and Robin E. McGuffin (Stites & Harbison, PLLC) will cast light on the profound impact of significant legal cases on the interpretation and enforceability of restrictive covenants. Key topics covered in this [...]

AI Inventions and Patents: Drafting Patents for Successful Licensing and Enforcement of AI Technology

In the ever-changing field of artificial intelligence (AI), innovation serves as the foundation for progress. The act of patenting AI inventions goes beyond a mere legal procedure; it is a strategic step that safeguards your intellectual property, opens doors to commercial success, and advances technology. However, the journey to patent AI technology is far from straightforward, with a landscape filled with nuances, complexities, and unique challenges.

What’s Next in ESG Investments and ERISA’s Fiduciary Duties?

Under the Employee Retirement Income Security Act (ERISA), plan sponsors must act in the best interest of their beneficiaries. However, with the increasing demand for sustainable and socially responsible investments, ERISA fiduciaries are now under pressure to integrate Environmental, Social, and Governance (ESG) criteria into their portfolios. Furthermore, the US Department of Labor (DOL) issued new rules outlining the factors that fiduciaries should consider when making investment decisions. Hence, as the ESG investment space continues to evolve, financial and investment advisers must keep abreast of recent regulatory developments and emerging trends to ensure compliance with relevant laws. Join a panel of [...]

Unleashing R&D Tax Credits: Navigating Change for Maximum Benefit and Innovation

Discover how R&D tax credits can be a game-changer for businesses, regardless of size. These credits serve as a financial catalyst, effectively offsetting innovation costs and driving unprecedented growth. However, staying up to date in the ever-evolving R&D tax credit landscape can be challenging, with new regulations and guidance emerging regularly.

Asbestos Litigation Trends: Understanding Disease, Jurisdiction, and Plaintiff Firm Strategies

Asbestos litigation remains a dynamic and pivotal facet of the legal realm, holding profound consequences for both victims and implicated industries. In this enlightening session, we will unravel the intricate factors that shape legal proceedings involving asbestos. Our panel of experts will delve into crucial subjects, encompassing recent advancements in diagnosing and treating asbestos-related diseases, navigating the complexities of jurisdictional challenges within asbestos cases, and elucidating the strategic approaches employed by plaintiff firms to construct formidable cases. Furthermore, we will scrutinize contemporary trends within asbestos litigation, dissecting the legal intricacies and regulations that exert influence on this legal domain.

Navigating Challenges in Patent Damages Analysis: Key Considerations for Litigants and Counsel

Damages in patent infringement cases are nearly always hotly contested, in part because the underlying case law involving lost profits and reasonable royalties can be confusing and sometimes seemingly contradictory. Parties routinely engage in motion practice resulting in the exclusion of damages opinions, potentially derailing a case. Thus, it is imperative for both litigants and counsel to stay abreast of the latest trends and developments in patent damages to sidestep potential pitfalls.

Winning Trial Strategies: Tactics and Defenses Explored

Preparing for a trial involves determining how to leverage documents. Strategizing a compelling narrative not only simplifies complex legal arguments but also leaves a lasting impression that can sway decisions in your client’s favor. Hence, at the early stages of any case, establishing a trial preparation strategy is crucial and should start taking shape during document review.

Critical Issues in Hatch-Waxman Litigation

The pharmaceutical labeling carve-out regulations remain a source of complexity in several cases. The Hatch-Waxman Act created a way for the Food and Drug Administration (FDA) to approve generic drugs even if they omit information about protected use to encourage competition among generic products. However, following the Teva v. GSK ruling, businesses must exercise caution and recognize the intricate relationship between Orange Book listed use patents, reference listed drug's prescribing information, and promotional labeling and other related activities. Furthermore, as other skinny-labeling-related cases continue to emerge which emphasize the need for legal professionals, businesses and other practitioners to remain up-to-date [...]

Avoiding Insurance Bad Faith Claims: A Guide for Policyholders and Insurers

Bad faith litigation remains complex and risky due to unprecedented legal developments and challenges that continue to emerge. Recent court rulings highlight how insurance companies can still be accountable for bad faith if they unreasonably refuse to settle and the policyholder wins at trial. As the evolving regulatory landscape continues to bring new issues that could affect how “bad faith” applies in future cases, insurers should stay informed to effectively manage their business operations in compliance with legal requirements. Listen as a panel of distinguished experts organized by The Knowledge Group provides a comprehensive discussion of the latest regulatory trends [...]

Dismiss

Go to Top